Pneumococcal conjugate vaccine

BIOLOGICAL15 trials

Sponsors

Public Health England, Wyeth is now a wholly owned subsidiary of Pfizer, Henry M. Jackson Foundation for the Advancement of Military Medicine, Novartis, Helsinki University Central Hospital

Conditions

HIV InfectionsMeningitisMeningococcal InfectionPneumococcal DiseasePneumococcal ImmunizationPneumococcal InfectionPneumococcal InfectionsPneumococcal Pneumonia

Phase 1

A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

CompletedNCT02892812

LG Life SciencesPneumococcal Infections

Start: 2016-09-30End: 2016-11-30Updated: 2017-06-26

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

CompletedNCT03109600

PT Bio FarmaSafety Issues

Start: 2017-04-18End: 2018-02-19Updated: 2018-03-06

Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)

CompletedNCT06698198

Sanofi Pasteur, a Sanofi CompanyPneumococcal Immunization

Start: 2018-12-03End: 2019-09-30Updated: 2024-11-20

Phase 2

Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults

CompletedNCT00197821

Public Health EnglandStreptococcus Pneumoniae

Start: 2004-01-31End: 2008-12-31Updated: 2012-03-28

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants

CompletedNCT01229176

NovartisTyphoid Fever

Start: 2011-03-31End: 2012-06-30Updated: 2014-05-01

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants

CompletedNCT01437267

NovartisTyphoid Fever

Start: 2011-10-31End: 2012-08-31Updated: 2014-04-10

Phase 3

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

CompletedNCT00622843

Henry M. Jackson Foundation for the Advancement of Military MedicineHIV Infections, Streptococcus Pneumoniae

Start: 2002-12-31End: 2013-07-31Updated: 2025-06-08

Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

CompletedNCT00806195

NovartisMeningitis, Meningococcal Infection

Start: 2008-12-31End: 2011-11-30Updated: 2013-07-09

Phase 4

Targeting of Immune Response After Pneumococcal Vaccination

CompletedNCT01402245

Helsinki University Central HospitalPneumococcal Pneumonia

Start: 2005-01-31End: 2010-06-30Updated: 2011-07-26

Pneumococcal Vaccine Schedules

RecruitingPACTR202105646878477

London School of Hygiene and Tropical Medicinepneumococci

Start: 2018-11-01Target: 40000Updated: 2026-01-27

Pneumococcal Vaccine Schedules Acquisition-Immunogenicity

RecruitingPACTR202105670402672

London School of Hygiene and Tropical MedicinePneumococcal acquisition and vaccine immunogenicity

Start: 2020-07-01Target: 784Updated: 2026-01-27

Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced People

Active, not recruitingNCT04945681

London School of Hygiene and Tropical MedicinePneumococcal Infections

Start: 2022-11-27End: 2026-02-28Updated: 2025-06-04

Opportunistic Pneumococcal Immunisation Trial in MALnutrition

Not yet recruitingNCT06817421

Nick FancourtPneumococcal Disease, Pneumococcal Infection, Pneumococcal Vaccines +2

Start: 2026-01-31End: 2029-02-28Target: 214Updated: 2025-12-18

Unknown Phase

Safety and Local Tolerability of Prevenar in Indian Children

CompletedNCT00488800

Wyeth is now a wholly owned subsidiary of PfizerPneumococcal Infections

Start: 2006-07-31End: 2007-01-31Target: 1000Updated: 2007-12-28

Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients

CompletedNCT02547493

University Hospital, MontpellierRheumatoid Arthritis

Start: 2016-03-03End: 2021-01-18Updated: 2022-01-03

Related Papers

Safety and coverage of Pneumosil pneumococcal polysaccharide conjugate vaccine (10-valent PCV) in a camp for internally displaced persons in Somaliland.

2025-11-19

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.

2013-11-2899 citations

A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.

2010-10-0150 citations

The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years.

2009-11-01105 citations